News

Novel monoclonal antibodies NA8 and NE12 can neutralize most SARS-CoV-2 variants and Omicron subvariants

By 71 views
0
Science Instruments in laboratory room. Science Research Concept.

Researchers generated and characterized two monoclonal antibodies (NA8 and NE12) that target the receptor binding domain of the SARS-CoV-2 spike protein, and exhibit neutralizing activity against major SARS-CoV-2 variants of concern.

Artificial intelligence-based model predicts patients’ risk of acute kidney injury

Previous article

High levels of sweet and fruit-flavor chemicals found in ‘tobacco-flavored’ e-cigarette liquids

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News